132 related articles for article (PubMed ID: 35078571)
1. [Bioinformatic analysis of differentially expressed genes and immune cell infiltration in primary biliary cholangitis patients with poor response to ursodeoxycholic acid therapy].
Li L; Song Y; Chen X; Huang Y; Liu H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jan; 38(1):16-23. PubMed ID: 35078571
[TBL] [Abstract][Full Text] [Related]
2. Decreased infiltration of CD4
Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study.
Yang H; Yang H; Wang L; Shi H; Liu B; Lin X; Chang Q; Chen JDZ; Duan Z
BMC Complement Med Ther; 2020 Aug; 20(1):242. PubMed ID: 32738911
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
Harms MH; van Buuren HR; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Hirschfield GM; Parés A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Lammers WJ; Hansen BE; van der Meer AJ
J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847
[TBL] [Abstract][Full Text] [Related]
5. Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells.
Mulcahy V; Liaskou E; Martin JE; Kotagiri P; Badrock J; Jones RL; Rushbrook SM; Ryder SD; Thorburn D; Taylor-Robinson SD; Clark G; Cordell HJ; Sandford RN; Jones DE; Hirschfield GM; Mells GF
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 37026715
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analysis of key biomarkers and immune filtration of skin biopsy in discoid lupus erythematosus.
Xiang M; Chen Q; Feng Y; Wang Y; Wang J; Liang J; Xu J
Lupus; 2021 Apr; 30(5):807-817. PubMed ID: 33530816
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
8. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ursodeoxycholic acid with traditional Chinese medicine on biochemical response in patients with primary biliary cholangitis: a real-world cohort study].
Chen JL; Yang X; Zhang Q; Sun L; Liu Y; Zhu BB; Wang XB
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):909-915. PubMed ID: 30669783
[No Abstract] [Full Text] [Related]
10. Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.
Cortez-Pinto H; Liberal R; Lopes S; Machado MV; Carvalho J; Dias T; Santos A; Agostinho C; Figueiredo P; Loureiro R; Martins A; Alexandrino G; Cotrim I; Leal C; Presa J; Mesquita M; Nunes J; Gouveia C; Vale AHE; Alves AL; Coelho M; Maia L; Pedroto I; Banhudo A; Pinto JS; Gomes MV; Oliveira J; Andreozzi V; Calinas F
United European Gastroenterol J; 2021 Jul; 9(6):699-706. PubMed ID: 34102008
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid impairs liver-infiltrating T-cell chemotaxis through IFN-γ and CX3CL1 production in primary biliary cholangitis.
Shimoyama S; Kawata K; Ohta K; Chida T; Suzuki T; Tsuneyama K; Shimoda S; Kurono N; Leung PSC; Gershwin ME; Suda T; Kobayashi Y
Eur J Immunol; 2021 Jun; 51(6):1519-1530. PubMed ID: 33710617
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Yuan Z; Jia G; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
[TBL] [Abstract][Full Text] [Related]
13. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis.
Zhao X; Zhang L; Wang J; Zhang M; Song Z; Ni B; You Y
J Transl Med; 2021 Jan; 19(1):35. PubMed ID: 33468161
[TBL] [Abstract][Full Text] [Related]
14. Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study.
Örnolfsson KT; Lund SH; Olafsson S; Bergmann OM; Björnsson ES
Scand J Gastroenterol; 2019 May; 54(5):609-616. PubMed ID: 31074667
[No Abstract] [Full Text] [Related]
15. Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis.
Tian S; Hu Y; Zhang M; Wang K; Guo G; Li B; Shang Y; Han Y
Arthritis Res Ther; 2023 Oct; 25(1):186. PubMed ID: 37784152
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators.
Qian JD; Yao TT; Wang Y; Wang GQ
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):874-884. PubMed ID: 32305248
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
18. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
[TBL] [Abstract][Full Text] [Related]
19. Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis.
Xiu MX; Liu YM; Chen GY; Hu C; Kuang BH
Dig Dis Sci; 2021 Sep; 66(9):3002-3014. PubMed ID: 32974809
[TBL] [Abstract][Full Text] [Related]
20. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L
Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]